The industry met a new milestone in the regulatory field this part year – 2011 saw a seven year high of FDA approvals with 30 drug approvals. Among those receiving multiple approvals were Johnson & Johnson and GlaxoSmithKline. Will that number stay high in 2012 and in years to come? To find out more, click here.
